Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Liraglutide biobetter by BioLingus for Type 2 Diabetes: Likelihood of Approval
Liraglutide biobetter is under clinical development by BioLingus and currently in Phase II for Type 2 Diabetes. According to GlobalData,...
Data Insights
Liraglutide biobetter by BioLingus for Obesity: Likelihood of Approval
Liraglutide biobetter is under clinical development by BioLingus and currently in Phase II for Obesity. According to GlobalData, Phase II...